Journal articleNeurosurgery · August 1, 2026
BACKGROUND AND OBJECTIVES: Traumatic brain injury (TBI) is one of the leading causes of mortality worldwide. Low- and middle-income countries have limited access to computed tomography scans (CT), which are essential in TBI care. The Infrascanner 2000™ is ...
Full textLink to itemCite
Journal articleJ Imaging Inform Med · July 17, 2026
Ischemic stroke management is time-sensitive, and lesion segmentation supports treatment selection, prognostication, and reproducible quantification. Deep learning (DL) aims to accelerate and standardize lesion delineation to augment neuroimaging workflows ...
Full textLink to itemCite
Journal articleJ Telemed Telecare · February 2026
BackgroundEvolving stroke care demands careful screening of stroke patients to ensure the right care is administered to the right patients in a timely manner. Telestroke has been increasingly utilized to improve access to stroke specialists to make these a ...
Full textLink to itemCite
Journal articleEpilepsia · November 2025
OBJECTIVE: Establishing the prevalence of epilepsy in Uganda is crucial to inform interventions and public policy. We conducted a nationwide survey to determine epilepsy prevalence. METHODS: From January 2019 to July 2022, a door-to-door survey was conduct ...
Full textLink to itemCite
Journal articleNeurol Clin Pract · August 2025
BACKGROUND AND OBJECTIVES: The field of neurology lacks neurocritical care (NCC) quality measures because of the complexity of neurologic disorders and challenges in data collection, hindering efforts to assess care quality and improve patient outcomes. Th ...
Full textLink to itemCite
Journal articleJ Neurosurg Pediatr · March 1, 2025
OBJECTIVE: The Endoscopic Third Ventriculostomy Success Score (ETVSS) is a useful decision-making heuristic when considering the probability of surgical success, defined traditionally as no repeat cerebrospinal fluid diversion surgery needed within 6 month ...
Full textLink to itemCite
Journal articleJ Stroke Cerebrovasc Dis · December 2024
BACKGROUND: Oral anticoagulation (OAC) is a risk factor for intracerebral hemorrhage (ICH) which is an important source of disability and mortality. OAC-associated ICH (OAC-ICH) patients have worse outcomes as compared to ICH patients not on OAC, likely be ...
Full textLink to itemCite
Journal articleNeurol Res · April 2024
Traumatic brain injury (TBI) from closed-head trauma is a leading cause of disability, with limited effective interventions. Many TBI models impact brain parenchyma directly, and are limited by the fact that these forces do not recapitulate clinically rele ...
Full textLink to itemCite
Journal articleAm Heart J · March 2024
BACKGROUND: Despite guidelines and strong evidence supporting intravenous thrombolysis and endovascular thrombectomy for acute stroke, access to these interventions remains a challenge. The objective of the IMPROVE stroke care program was to accelerate acu ...
Full textLink to itemCite
Journal articleTrials · February 28, 2024
BACKGROUND: Recruitment of participants is the greatest risk to completion of most clinical trials, with 20-40% of trials failing to reach the targeted enrollment. This is particularly true of trials of central nervous system (CNS) therapies such as interv ...
Full textLink to itemCite
Journal articleCommun Biol · March 9, 2023
The underlying etiologies of seizures are highly heterogeneous and remain incompletely understood. While studying the unfolded protein response (UPR) pathways in the brain, we unexpectedly discovered that transgenic mice (XBP1s-TG) expressing spliced X-box ...
Full textLink to itemCite
Journal articleJ Stroke Cerebrovasc Dis · March 2023
OBJECTIVE: Constrained resources at tertiary centers indicate a need for re-exploration of the practice of routinely transferring all community hospital patients with complex conditions such as hemorrhagic stroke (ICH). We addressed the clinical question o ...
Full textLink to itemCite
Journal articleEpilepsy Behav · January 2023
OBJECTIVE: This study evaluated an epilepsy training program for healthcare workers that was designed to improve their knowledge of epilepsy, its treatment, and its psychosocial effects. METHODS: This single group, before and after survey was conducted in ...
Full textLink to itemCite
Journal articleFront Stroke · 2023
BACKGROUND AND HYPOTHESIS: At present, there are no medical interventions proven to improve functional recovery in patients with subacute stroke. We hypothesize that the intraparenchymal administration of CTX0E03, a conditionally immortalized neural stem c ...
Full textLink to itemCite
Journal articleExp Brain Res · September 2022
The treatment of traumatic brain injury (TBI) in military populations is hindered by underreporting and underdiagnosis. Clinical symptoms and outcomes may be mitigated with an effective pre-injury prophylaxis. This study evaluates whether CN-105, a 5-amino ...
Full textLink to itemCite
Journal articleJAMA Cardiol · July 1, 2022
IMPORTANCE: Data are limited regarding the risk of cerebrovascular ischemic events and major bleeding in patients with atrial fibrillation (AF) and recent acute coronary syndrome (ACS) and/or percutaneous coronary intervention (PCI). OBJECTIVE: Determine t ...
Full textLink to itemCite
Journal articleNeurosurgery · June 1, 2022
BACKGROUND: Current traumatic brain injury (TBI) prognostic calculators are commonly used to predict the mortality and Glasgow Outcome Scale, but these outcomes are most relevant for severe TBI. Because mild and moderate TBI rarely reaches severe outcomes, ...
Full textLink to itemCite
Journal articleNeurosurgery · May 1, 2022
BACKGROUND: Machine learning (ML) holds promise as a tool to guide clinical decision making by predicting in-hospital mortality for patients with traumatic brain injury (TBI). Previous models such as the international mission for prognosis and clinical tri ...
Full textLink to itemCite
Journal articleStereotact Funct Neurosurg · 2022
INTRODUCTION: Stereotactic neurosurgical techniques are increasingly used to deliver biologics, such as cells and viruses, although standardized procedures are necessary to ensure consistency and reproducibility. OBJECTIVE: We provide an instructional guid ...
Full textLink to itemCite
Journal articleBMJ Neurol Open · 2022
BACKGROUND/PURPOSE: Cardiac arrest is a common cause of death and neurological injury; therapeutic cooling for neuroprotection is standard of care. Despite numerous and ongoing trials targeting a specified cooling temperature for a target duration, the con ...
Full textOpen AccessLink to itemCite
Journal articleJ Neurosurg · November 1, 2021
OBJECTIVE: The purpose of this study was to investigate whether neurosurgical intervention for traumatic brain injury (TBI) is associated with reduced risks of death and clinical deterioration in a low-income country with a relatively high neurosurgical ca ...
Full textLink to itemCite
Journal articleNeurohospitalist · October 2021
BACKGROUND AND PURPOSE: Rates of emergency medical services (EMS) utilization for acute stroke remain low nationwide, despite the time-sensitive nature of the disease. Prior research suggests several demographic and social factors are associated with EMS u ...
Full textLink to itemCite
Journal articleEpilepsy Behav · January 2021
OBJECTIVE: Epilepsy is a global public health concern, with the majority of cases occurring in lower- and middle-income countries where the treatment gap remains formidable. In this study, we simultaneously explore how beliefs about epilepsy causation, per ...
Full textLink to itemCite
Journal articleEpilepsy Behav · January 2021
OBJECTIVE: This study sets out to describe the current demographics of people with epilepsy (PWE) attending hospital-based care in Uganda and the epilepsy treatment practices within three of the largest Ugandan public referral hospitals. METHODS: In a six- ...
Full textLink to itemCite
Journal articleEpilepsy Behav · January 2021
In this summary paper, we review the body of research contained in this special issue, The Intersection of Culture, Resources, and Disease: Epilepsy Care in Uganda, and corollary recommendations for a way forward. We review key findings and conclusions for ...
Full textLink to itemCite
Journal articleEpilepsy Behav · January 2021
OBJECTIVE: Epilepsy, a neurological disorder with effective biomedical treatment, remains largely untreated in Uganda. Potential reasons for this treatment gap (TG) include limited access to trained providers and clinics, social stigmata of seizures, cultu ...
Full textLink to itemCite
Journal articleInformatics in Medicine Unlocked · January 1, 2021
Despite evidence to suggest that as many as 30% of hospitalized patients with altered mental status may be having subclinical seizures for which treatment may improve patient outcomes, the adoption of continuous video electroencephalography (EEG) monitorin ...
Full textCite
Journal articleBrain Res · April 15, 2020
Alzheimer's disease (AD) is the most common form of dementia and is characterized pathologically by Aβ plaques. Current treatments are purely symptomatic despite decades of intensive research interest. Notably, patients with the APOE4 allele are at increas ...
Full textLink to itemCite
Journal articleAm Heart J · April 2020
The AHA Guidelines recommend developing multi-tiered systems for the care of patients with acute stroke.1 An ideal stroke system of care should ensure that all patients receive the most efficient and timely care, regardless of how they first enter or acces ...
Full textLink to itemCite
Journal articleNeurotherapeutics · April 2020
Autoimmune encephalitis (AE) is a group of disorders causing synaptic receptor dysfunction with a broad range of neurological symptoms that has been historically difficult to differentiate clinically. Today, AE represents an excellent example of the rapid ...
Full textLink to itemCite
Journal articleJ Am Coll Cardiol · January 21, 2020
BACKGROUND: Lipoprotein(a) concentration is associated with cardiovascular events. Alirocumab, a proprotein convertase subtilisin/kexin type 9 inhibitor, lowers lipoprotein(a) and low-density lipoprotein cholesterol (LDL-C). OBJECTIVES: A pre-specified ana ...
Full textLink to itemCite
Journal articleInformatics in Medicine Unlocked · January 1, 2020
This study aimed to investigate how intermittent ICU data documented by nursing in the electronic medical record (EMR) corresponds to that obtained from continuous data acquisition (CDA) and the differences in perception by medical providers. Both descript ...
Full textCite
Journal articleSN Compr Clin Med · 2020
The concurrence of COVID-19 with Guillain-Barre syndrome (GBS) can increase the likelihood of neuromuscular respiratory failure, autonomic dysfunction, and other life-threatening symptoms. Currently, very little is known about the underlying mechanisms, cl ...
Full textOpen AccessLink to itemCite
Journal articleCirculation · November 5, 2019
BACKGROUND: The 2018 US cholesterol management guidelines recommend additional lipid-lowering therapies for secondary prevention in patients with low-density lipoprotein cholesterol ≥70 mg/dL or non-high-density lipoprotein cholesterol ≥100 mg/dL despite m ...
Full textLink to itemCite
Journal articleCirc Cardiovasc Qual Outcomes · November 2019
BACKGROUND: In ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab), alirocumab was compared with placebo, added to high-intensity or maximum tolerated statin treatment after acute coron ...
Full textLink to itemCite
Journal articleJ Am Coll Cardiol · September 3, 2019
BACKGROUND: Patients with acute coronary syndrome (ACS) and concomitant noncoronary atherosclerosis have a high risk of major adverse cardiovascular events (MACEs) and death. The impact of lipid lowering by proprotein convertase subtilisin-kexin type 9 inh ...
Full textLink to itemCite
Journal articleJ Am Coll Cardiol · September 3, 2019
BACKGROUND: Patients with acute coronary syndrome (ACS) and history of coronary artery bypass grafting (CABG) are at high risk for recurrent cardiovascular events and death. OBJECTIVES: This study sought to determine the clinical benefit of adding alirocum ...
Full textLink to itemCite
Journal articleEur Heart J · September 1, 2019
AIMS: The third Universal Definition of Myocardial Infarction (MI) Task Force classified MIs into five types: Type 1, spontaneous; Type 2, related to oxygen supply/demand imbalance; Type 3, fatal without ascertainment of cardiac biomarkers; Type 4, related ...
Full textLink to itemCite
Journal articleLancet Diabetes Endocrinol · August 2019
BACKGROUND: After acute coronary syndrome, diabetes conveys an excess risk of ischaemic cardiovascular events. A reduction in mean LDL cholesterol to 1·4-1·8 mmol/L with ezetimibe or statins reduces cardiovascular events in patients with an acute coronary ...
Full textLink to itemCite
Journal articleCirculation · July 9, 2019
BACKGROUND: Previous trials of PCSK9 (proprotein convertase subtilisin-kexin type 9) inhibitors demonstrated reductions in major adverse cardiovascular events, but not death. We assessed the effects of alirocumab on death after index acute coronary syndrom ...
Full textLink to itemCite
Journal articleStroke · June 2019
Background and Purpose- Predictors of stroke and transient ischemic attack (TIA) in patients with peripheral artery disease (PAD) are poorly understood. The primary aims of this analysis were to (1) determine the incidence of ischemic/hemorrhagic stroke an ...
Full textOpen AccessLink to itemCite
Journal articleJ Am Coll Cardiol · February 5, 2019
BACKGROUND: The ODYSSEY OUTCOMES (Evaluation of Cardiovascular Outcomes After an Acute Coronary Syndrome During Treatment With Alirocumab) trial compared alirocumab with placebo, added to high-intensity or maximum-tolerated statin treatment, after acute co ...
Full textLink to itemCite
Journal articleJ Am Heart Assoc · December 18, 2018
Background Vorapaxar, a protease-activated receptor-1 antagonist, is approved for secondary prevention of cardiovascular events but is associated with increased intracranial hemorrhage. Methods and Results TRACER (Thrombin Receptor Antagonist for Clinical ...
Full textLink to itemCite
Journal articleStroke Vasc Neurol · December 2018
OBJECTIVE: Subarachnoid haemorrhage (SAH) accounts for 3% of all strokes, and is associated with significant morbidity and mortality. There is growing evidence implicating apolipoprotein E (apoE) in mediating adaptive anti-inflammatory and neuroprotective ...
Full textLink to itemCite
Journal articleN Engl J Med · November 29, 2018
BACKGROUND: Patients who have had an acute coronary syndrome are at high risk for recurrent ischemic cardiovascular events. We sought to determine whether alirocumab, a human monoclonal antibody to proprotein convertase subtilisin-kexin type 9 (PCSK9), wou ...
Full textLink to itemCite
Journal articleLancet · October 27, 2018
BACKGROUND: Glucagon-like peptide 1 receptor agonists differ in chemical structure, duration of action, and in their effects on clinical outcomes. The cardiovascular effects of once-weekly albiglutide in type 2 diabetes are unknown. We aimed to determine t ...
Full textLink to itemCite
Journal articleAnn Neurol · June 2018
OBJECTIVE: The optimal treatment of nonconvulsive seizures in critically ill patients is uncertain. We evaluated the comparative effectiveness of the antiseizure drugs lacosamide (LCM) and fosphenytoin (fPHT) in this population. METHODS: The TRENdS (Treatm ...
Full textLink to itemCite
Journal articleNeurocrit Care · April 2018
BACKGROUND: Despite data indicating the importance of continuous video-electroencephalography (cvEEG) monitoring, adoption has been slow outside major academic centers. Barriers to adoption include the need for technologists, equipment, and cvEEG readers. ...
Full textLink to itemCite
Journal articleClin Cardiol · October 2017
BACKGROUND: In 2011, the US Food and Drug Administration requested that GlaxoSmithKline perform retrospective adjudication of cardiovascular (CV) events reported in the bupropion drug-development trials for smoking cessation. HYPOTHESIS: Retrospective adju ...
Full textLink to itemCite
Journal articleBlood · June 1, 2017
We investigated the frequency and characteristics of intracranial hemorrhage (ICH), the factors associated with the risk of ICH, and outcomes post-ICH overall and by randomized treatment. We identified patients with ICH from the overall trial population en ...
Full textLink to itemCite
Journal articleSci Rep · April 21, 2017
At present, there are no proven pharmacological treatments demonstrated to improve long term functional outcomes following traumatic brain injury(TBI). In the setting of non-penetrating TBI, sterile brain inflammatory responses are associated with the deve ...
Full textLink to itemCite
Journal articleAnn Clin Transl Neurol · April 2017
OBJECTIVE: At present, the absence of a pharmacological neuroprotectant represents an important unmet clinical need in the treatment of ischemic and traumatic brain injury. Recent evidence suggests that administration of apolipoprotein E mimetic therapies ...
Full textLink to itemCite
Journal articleJ Am Heart Assoc · September 13, 2016
BACKGROUND: The PCSK9 antibody alirocumab (75 mg every 2 weeks; Q2W) as monotherapy reduced low-density lipoprotein-cholesterol (LDL-C) levels by 47%. Because the option of a monthly dosing regimen is convenient, ODYSSEY CHOICE II evaluated alirocumab 150 ...
Full textLink to itemCite
Journal articleN Engl J Med · August 11, 2016
BACKGROUND: Patients with acute medical illnesses are at prolonged risk for venous thrombosis. However, the appropriate duration of thromboprophylaxis remains unknown. METHODS: Patients who were hospitalized for acute medical illnesses were randomly assign ...
Full textLink to itemCite
Journal articleClin Neurophysiol · September 2015
OBJECTIVE: This study investigated inter-rater agreement (IRA) among EEG experts for the identification of electrographic seizures and periodic discharges (PDs) in continuous ICU EEG recordings. METHODS: Eight board-certified EEG experts independently iden ...
Full textLink to itemCite
Journal articleJ Clin Neurophysiol · August 2015
PURPOSE: To evaluate the sensitivity and specificity of a panel of quantitative EEG (qEEG) trends for seizure detection in adult intensive care unit (ICU) patients when reviewed by neurophysiologists and non-neurophysiologists. METHODS: One hour qEEG panel ...
Full textOpen AccessLink to itemCite
Journal articleJ Clin Neurophysiol · June 2014
PURPOSE: The purpose of this study was to determine the relative cost reductions within different staffing models for continuous video-electroencephalography (cvEEG) service by introducing a template system for 10/20 lead application. METHODS: We compared ...
Full textLink to itemCite
Journal articleAnnu Int Conf IEEE Eng Med Biol Soc · 2014
An implanted electroencephalogram (EEG) recorder would help diagnose infrequent seizure-like events. A proof-of-concept study quantified the electrical characteristics of the electrodes planned for the proposed recorder. The electrodes were implanted in an ...
Full textLink to itemCite
Journal articleJ Neurosci Res · October 2013
During development, neuronal activity is used as a cue to guide synaptic rearrangements to refine connections. Many studies, especially in the visual system, have shown that the N-methyl-D-aspartate receptor (NMDAr) plays a key role in mediating activity-d ...
Full textLink to itemCite
Journal articleEpilepsia · October 2013
PURPOSE: There is a gap in our knowledge of the factors that modulate the predisposition to seizures following perinatal hypoxia. Herein, we investigate in a mouse model the effects of two distinct factors: developmental stage after the occurrence of the p ...
Full textLink to itemCite
Journal articleNeurocrit Care · August 2013
BACKGROUND: Use of antiepileptic drugs (AED's) is common in the neurocritical care setting. However, there remains a great deal of controversy regarding the optimal agent. Studies associating the prophylactic use of AED's with poor outcomes are heavily bia ...
Full textLink to itemCite
Journal articleJ Stroke Cerebrovasc Dis · May 2013
OBJECTIVE: To describe the length of time physicians spend completing telestroke consultations and examine factors associated with that period. METHODS: This is a retrospective review of data from telestroke software. Clinical data obtained between July 20 ...
Full textLink to itemCite
Journal articleNeurocrit Care · February 2012
BACKGROUND: There were nearly 700,000 patients in the United States in 2010 living with brain tumor diagnoses. The incidence of seizures in this population is as high as 70% and is historically difficult to control. Approximately 30-40% of brain tumors pat ...
Full textOpen AccessLink to itemCite
Journal articleJ Clin Neurophysiol · February 2012
The purpose of this study was to compare the quality of the electroencephalographic (EEG) data obtained with a BraiNet template in a practical use setting, to that obtained with standard 10/20 spaced, technologist-applied, collodion-based disk leads. Pairs ...
Full textLink to itemCite
Journal articleJ Neurointerv Surg · March 2011
Dural venous sinus thrombosis (DVST) is a pathological phenomenon resulting from vascular occlusion of the cerebral venous sinuses. The mainstay of therapy for DVST is anticoagulation but more aggressive interventional therapies must be considered when med ...
Full textLink to itemCite
Journal articleNeurocrit Care · December 2010
BACKGROUND: Studies devoted to intensive glucose control suggested that the intensive insulin therapy (IIT) approach could effectively reduce complications associated with critical illness. A program of IIT with the goal of achieving a blood glucose of 80- ...
Full textLink to itemCite
Journal articleStroke · October 2010
Despite advances in aneurysm ablation and the initial management of patients presenting with aneurysmal subarachnoid hemorrhage, delayed cerebral ischemia remains a significant source of morbidity. Traditionally, delayed cerebral ischemia was thought to be ...
Full textLink to itemCite
Journal articleEpilepsia · May 2007
PURPOSE: Because of the high incidence of nonconvulsive status epilepticus (NCSE), the attraction of a "quick and easy" screening electroencephalogram (EEG) is obvious. Previous studies have shown utility of hairline EEG in diagnosing epilepsy. However, th ...
Full textLink to itemCite
Journal articleClin Neuropharmacol · 2006
Parkinson disease is one of the most common neurodegenerative diseases in the United States, and the number of late stage patients is rising. In advance-stage disease, fluctuations in motor function, variability in response to dopaminergic therapy, and dys ...
Full textLink to itemCite
Journal articleAm J Hematol · December 2002
We report herein a case of Factor XIII deficiency that remained undiagnosed until 2 years of age. Part of the delay in diagnosis was a consequence of testing that was performed on a blood sample obtained after plasma transfusion therapy for a life-threaten ...
Full textLink to itemCite
Journal articleJ Neurosci · April 1, 2002
During development, waves of activity periodically spread across retina to produce correlated activity that is thought to drive activity-dependent ordering in optic fibers. We asked whether similar waves of activity are produced in the retina of adult gold ...
Full textLink to itemCite
Journal articleJ Neurosci · January 1, 2000
Spontaneous (not retinally driven) postsynaptic activity was examined during activity-dependent refinement of optic fibers in the goldfish tectum. Unit recordings in vivo and in vitro demonstrated that spontaneous tectal activity increased to 150% of norma ...
Full textLink to itemCite